Press release PEP-Therapy receives FDA Orphan Drug Designation for PEP-010for treatment of Pancreatic Cancer Paris (France), March 17, 2025 – PEP-Therapy, a clinical-stage biotechnology company ...

Enhertu is a combination of a chemotherapy drug and targeted therapy. This type of therapy differs from immunotherapy. Doctors prescribe Enhertu for certain types of breast, lung, and other ...

Researchers at UT Southwestern Medical Center found that tenecteplase, a newer drug, is just as safe and effective as ...

The measure, which passed with bipartisan support and minor changes, now heads back to the House. It is just the second ...

R-EPOCH is a cancer treatment that combines six chemotherapy drugs. Combination therapies often work better than single drugs because they each fight cancer cells in different ways. R-EPOCH is ...

Medicare covers prescribed chemotherapy drugs. How and where a person receives chemotherapy helps determine which Medicare part provides the coverage. When a person receives a cancer diagnosis ...